Philip W. Lavori

Publication Details

• Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer.

  Lee P, Bazan JG, Lavori PW, Weerasuriya DK, Quon A, Le QT, Wakelee HA, Graves EE, Loo BW. Clin Lung Cancer. 2012; 13 (1): 52-8

  Fluorine-18 flurodeoxyglucose positron emission tomography (FDG-PET) imaging has rapidly become the standard of care for staging patients with lung cancer. We evaluated the prognostic value of metabolic tumor volume (MTV), a measure of tumor burden on FDG-PET imaging, in patients with non-small-cell lung cancer (NSCLC) treated definitively.

  PubMedID: 21703935